Stefan Brazda has been Manager Operational Excellence at Takeda since 2019, being responsible for processes and strategy. Prior to this, for more than 10 years, he worked as portfolio manager and lean specialist, among others, at Burgwedel Biotech and MSD.

Markus Ristl is IT System Owner MES (PAS-X 3.2.x) and IT Business Partner at Takeda. He has more than 20 years of IT experience, working among others at Shire, Baxalta, and Baxter International.

Creating better health for people and a brighter future for the world is our purpose. The science and technology we advance are constantly evolving. But through our enduring values, our ambition remains steadfast. We strive to deliver truly transformative treatments, contributing significant value to society while creating an exceptional experience for our people. Our main areas of focus include Gastrointestinal and Inflammation, Rare Diseases, Plasma-Derived Therapies, Oncology, Neuroscience, and Vaccines.

Creating better health for people and a brighter future for the world is our purpose. The science and technology we advance are constantly evolving. But through our enduring values, our ambition remains steadfast. We strive to deliver truly transformative treatments, contributing significant value to society while creating an exceptional experience for our people. Our main areas of focus include Gastrointestinal and Inflammation, Rare Diseases, Plasma-Derived Therapies, Oncology, Neuroscience, and Vaccines.